In regenerative medicine, macrophages and stem cells play pivotal roles in repairing central nervous system (CNS) injuries. These cells are instrumental due ...

Despite new methodologies and flexible regulatory pathways, CNS biopharmaceuticals still face significant safety assessment ...

Nanomedicine, an interdisciplinary field merging the power of nanotechnology with the intricacies of medicine, has revolutionized healthcare on a scale previously unimaginable. By manipulating ...

Kite, a Gilead Company (Nasdaq: GILD), today announced the U.S. Food and Drug Administration (FDA) approved an update to the Yescarta® (axicabtagene ciloleucel) prescribing information removing the ...

Iopofosine I 131 Active in Treating Malignancies in the Brain; Confirmed Response in CNS Lymphoma Provides Additional Validation for Continued Development of Iopofosine in Multiple CNS Malignancies ...

Updated FDA labeling for Yescarta now includes patients with relapsed or refractory primary CNS lymphoma, expanding treatment options for this group.

Relationship between efficacy of phase I/II drug ispinesib in medulloblastoma, molecular subtypes, and p53-mutant status. This is an ASCO Meeting Abstract from the 2023 ASCO Annual Meeting I. This ...

How does the gut microbiota impact the nervous and mucosal immune systems? The enteric nervous system (ENS) consists of two ganglionated neural networks within the gut wall known as the myenteric and ...

SEQSTER has announced the expansion of its partnership with Praxis Precision Medicines to expedite clinical trials in central ...

- Portfolio available in 60+ markets and deepens our CNS footprint in Brazil, South Africa, France and Italy BASILDON, England--(BUSINESS WIRE)--PRESS RELEASE – FOR TRADE, BUSINESS AND MEDICAL MEDIA ...